How to buy Adial Pharmaceuticals stock (ADIL)

Adial Pharmaceuticals is a biotechnology business based in the US. Adial Pharmaceuticals shares (ADIL) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.02 – a decrease of 4.67% over the previous week. Adial Pharmaceuticals employs 4 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Adial Pharmaceuticals stock

Buy Adial Pharmaceuticals stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Adial Pharmaceuticals stock price (NASDAQ: ADIL)

Use our graph to track the performance of ADIL stocks over time.

Adial Pharmaceuticals shares at a glance

• Key figures

Information last updated 2024-12-25.

Latest market close	$1.02
52-week range	$0.77 - $4.17
50-day moving average more info button	$1.06
200-day moving average more info button	$1.23
Wall St. target price	$7.50
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-2.94

Is it a good time to buy Adial Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Adial Pharmaceuticals price performance over time

Historical closes compared with the close of $1.05 from 2024-12-24

1 week (2024-12-20)	-1.87%
1 month (2024-11-27)	5.95%
3 months (2024-09-27)	3.96%
6 months (2024-06-27)	-6.25%

1 year (2023-12-27)	-42.31%
2 years (2022-12-27)	-80.94%
3 years (2021-12-27)	66
5 years (2019-12-27)	61.25

Adial Pharmaceuticals financials

Gross profit TTM	$0
Return on assets TTM	-104.18%
Return on equity TTM	-320.96%
Profit margin	0%
Book value	$2.46
Market Capitalization more info button	$6.7 million

TTM: trailing 12 months

Adial Pharmaceuticals share dividends

We're not expecting Adial Pharmaceuticals to pay a dividend over the next 12 months.

Have Adial Pharmaceuticals's shares ever split?

Adial Pharmaceuticals's shares were split on a 1:25 basis on 6 August 2023 . So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Adial Pharmaceuticals shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Adial Pharmaceuticals shares which in turn could have impacted Adial Pharmaceuticals's share price.

Adial Pharmaceuticals share price volatility

Over the last 12 months, Adial Pharmaceuticals's shares have ranged in value from as little as $0.765 up to $4.1699. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Adial Pharmaceuticals's is 1.296. This would suggest that Adial Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Adial Pharmaceuticals overview

Adial Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia. .

Frequently asked questions

null
What percentage of Adial Pharmaceuticals is owned by insiders or institutions?
Currently 1.799% of Adial Pharmaceuticals shares are held by insiders and 3.03% by institutions. How many people work for Adial Pharmaceuticals?
Latest data suggests 4 work at Adial Pharmaceuticals. When does the fiscal year end for Adial Pharmaceuticals?
Adial Pharmaceuticals's fiscal year ends in December. Where is Adial Pharmaceuticals based?
Adial Pharmaceuticals's address is: 4870 Sadler Road, Glen Allen, VA, United States, 23060 What is Adial Pharmaceuticals's ISIN number?
Adial Pharmaceuticals's international securities identification number is: US00688A1060 What is Adial Pharmaceuticals's CUSIP number?
Adial Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 00688A106